Back
 IJOHNS  Vol.3 No.1 , January 2014
The Recurrence Rate of Pars Tensa Retraction Cholesteatoma and a New Staging System
Abstract:

Objective: To investigate the cumulative recurrence rate of pars tensa retraction cholesteatoma on the new staging system established by Japan Otological Society (JOS). Materials and Methods: It is a retrospective study and performed in a tertiary and academic center. The series comprised 71 patients with pars tensa retraction cholesteatoma who underwent surgical treatment by a single surgeon between 1994 and 2007. Results: The 10-year cumulative recurrence rate of pars tensa retraction cholesteatoma was 12.1% overall, 20.0% in Stage I, 14.4% in Stage II and 6.2% in Stage III. Conclusions: The JOS staging system for pars tensa retraction cholesteatoma did not reflect the prognosis. The development of a common international staging system for cholesteatoma in the future is desirable.

Cite this paper: Y. Mishiro, H. Katsura, T. Kitahara and M. Sakagami, "The Recurrence Rate of Pars Tensa Retraction Cholesteatoma and a New Staging System," International Journal of Otolaryngology and Head & Neck Surgery, Vol. 3 No. 1, 2014, pp. 1-3. doi: 10.4236/ijohns.2014.31001.
References

[1]   Y. Mishiro, M. Sakagami, T. Kitahara, K. Kondo and S. Okumura, “The Investigation of the Recurrence Rate of Cholesteatoma Using Kaplan-Meier Survival Analysis,” Otology & Neurotology, Vol. 29, No. 6, 2008, pp. 803-806. http://dx.doi.org/10.1097/MAO.0b013e318181337f

[2]   Japan Otological Society, “Cholesteatoma Staging System,” Otology Japan, Vol. 18, No. 5, 2008, pp. 611-615.

[3]   M. Hashimoto-Ikehara, Y. Mishiro, T. Kitahara and M. Sakagami, “The 10-Year Disease-Free Rate of Attic Cholesteatoma Based on a New Staging System,” Journal of International Advanced Otology, Vol. 7, No. 3, 2011, pp. 289-292.

[4]   Japan Otological Society, “Staging of Middle Ear Cholesteatoma,” Otology Japan, Vol. 20, No. 5, 2010, pp. 743-145.

[5]   S. E. Stangerup, D. Drozdziewics, M. Tos and A. H. Jenzen, “Recurrence Rate of Attic Cholesteatoma: Different Methods of Estimating Recurrence Rate,” Otolaryngology —Head and Neck Surgery, Vol. 123, No. 3, 2000, pp. 283-287. http://dx.doi.org/10.1067/mhn.2000.104666

[6]   W. P. Potsic, D. S. Samadi, R. R. Marsh and R. F. Wetmore, “A Staging System for Congenital Cholesteatoma,” Otolaryngology—Head and Neck Surgery, Vol. 128, No. 9, 2002, pp. 1009-1012.
http://dx.doi.org/10.1001/archotol.128.9.1009

[7]   G. Inoguchi, T. Okuno, Y. Hata, M. Baba and D. Sugiyama, “Congenital Cholesteatoma: Posterior Lesions and Staging System,” Annals of Otology, Rhinology, and Laryngology, Vol. 119, No. 7, 2010, pp. 490-494.

[8]   H. G. Choi, K. H. Park, S. N. Park, B. C. Jun, D. H. Lee, Y. S. Park, et al., “Clinical Experience of 71 Cases of Congenital Middle Ear Cholesteatoma,” Acta Oto-laryngologica, Vol. 130, No. 1, 2010, pp. 62-67.
http://dx.doi.org/10.3109/00016480902963079

[9]   J. Heermann Jr., H. Heermann and E. Kopstein, “Fascia and Cartilage Palisade Tympanoplasty: Nine Years Experience,” Otolaryngology—Head and Neck Surgery, Vol. 91, No. 3, 1970, pp. 228-241.
http://dx.doi.org/10.1001/archotol.1970.00770040334004

[10]   P. Caye-Thomasen, J. Anderson, C. Uzun, S. Hansen and M. Tos, “Ten-Year Results of Cartilage Palisades versus Fascia in Eardrum Reconstruction after Surgery for Sinus or Tensa Retraction Cholesteatoma in Children,” Laryngoscope, Vol. 119, No. 5, 2009, pp. 944-952.
http://dx.doi.org/10.1002/lary.20195

 
 
Top